Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders
- 1 April 1995
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 91 (s386) , 40-43
- https://doi.org/10.1111/j.1600-0447.1995.tb05923.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phenelzine vs Atenolol in Social PhobiaArchives of General Psychiatry, 1992
- Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitorEuropean Neuropsychopharmacology, 1992
- Moclobemide: a range of opportunitiesPsychopharmacology, 1992
- Depression and senile dementia of the Alzheimer type: a role for moclobemidePsychopharmacology, 1992
- Use of moclobemide in children with attention deficit hyperactivity disorderPsychopharmacology, 1992
- Cognitive-Behavioral and Pharmacological Treatments of Social PhobiaArchives of General Psychiatry, 1991
- Moclobemide and the reversible inhibitors of monoamine oxidase antidepressantsActa Psychiatrica Scandinavica, 1990
- Biochemical Aspects of the Pharmacology of MoclobemideThe British Journal of Psychiatry, 1989
- Editor's Preface: Antidepressants of the FutureThe British Journal of Psychiatry, 1989
- A Teacher Rating Scale for Use in Drug Studies with ChildrenAmerican Journal of Psychiatry, 1969